| Investigator |
Title |
Sponsor |
ID |
Dates |
Amount |
| Daniel Joe Lovell, MD |
Refining entry criteria and outcome measures for children with axial disease and spondyloarthritis: preparation for clinical trials |
Children's Hospital of Philadelphia (National Institutes of Health) |
3201900722 |
12/30/2019 - 12/29/2020 |
$7,550 |
| Esi M Morgan, MD |
Patients, Advocates and Rheumatology Teams Network for Research and Service (PARTNERS) – Phase III |
CARRA, Inc. |
PARTNERS;Carra |
04/01/2019 - 12/31/2019 |
$14,427 |
| Esi M Morgan, MD |
Enabling Real-time, Personalized Engagement in Research: an App-based Approach |
Children's Hospital Boston (Patient-Centered Outcome Research Inst.) |
EA-PPRN-00038 |
05/01/2019 - 04/30/2020 |
$17,000 |
| Esi M Morgan, MD |
Establishing a Rheumatology Learning Health System |
Dartmouth College (Arthritis Foundation) |
Morgan Dartmouth |
04/01/2018 - 03/31/2019 |
$44,000 |
| Esi M Morgan, MD |
PARTNERS |
Duke University (Patient-Centered Outcome Research Inst.) |
PPRN-1306-04601 |
09/13/2017 - 03/31/2019 |
$16,779 |
| Grant S Schulert, MD |
Monocyte and macrophage polarization in systemic juvenil |
National Institutes of Health (NIH) |
K08AR072075 |
08/01/2019 - 07/31/2020 |
$169,117 |
| Grant S Schulert, MD |
2019 Rheumatology Research Foundation CareerDevelopment Bridge Funding Award: K Supplement |
Rheumatology Research Foundation |
RRF_Schulert_19-21 |
09/16/2019 - 09/15/2020 |
$50,000 |
| Hermine Brunner, MD |
Pediatric musculOskeletal & RheumaTology Innovation COre center (PORTICO) |
National Institutes of Health (NIH) |
1P30AR076316 |
09/16/2019 - 06/30/2020 |
$694,264 |
| Jennifer L Huggins, MD |
Cincinnati Children's Pediatric Rheumatology Fellowship Training Program |
Rheumatology Research Foundation |
RRF_Huggins |
07/01/2019 - 06/30/2020 |
$50,000 |
| Sheila T Angeles-Han, MD |
A Randomized, Open Label, Multi-Center, Phase 3 Efficacy Study of Sub-Q Abatacept in Preventing Extension of Oligoarticular JIA (Limit-JIA) |
Duke University (Patient-Centered Outcome Research Inst.) |
Duke;236849 |
03/01/2020 - 02/28/2021 |
$27,490 |
| Sheila T Angeles-Han, MD |
Predicting uveitis onset in children with juvenile idiopathic arthritis |
National Institutes of Health (NIH) |
1R01EY030521 |
09/30/2019 - 06/30/2020 |
$690,085 |
| Sheila T Angeles-Han, MD |
Career Development Bridge Funding Award: R Bridge |
Rheumatology Research Foundation |
RRF;Angeles Han |
07/01/2019 - 06/30/2020 |
$100,000 |
| Sheila T Angeles-Han, MD |
Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial (ADJUST) "Study" |
The Univ of California, San Francisco (National Institutes of Health) |
11309sc_FEX |
10/23/2019 - 10/22/2020 |
$4,800 |
| Current Year Direct |
$1,885,512 |
